Similar articles for PMID: 36168329

Year	Number of Results
2020	30
2021	37
2022	29
2023	20
2024	5

1

Localized delivery of nanomedicine and antibodies for combating COVID-19.

Tu B, Gao Y, An X, Wang H, Huang Y. Tu B, et al. Acta Pharm Sin B. 2023 May;13(5):1828-1846. doi: 10.1016/j.apsb.2022.09.011. Epub 2022 Sep 23. Acta Pharm Sin B. 2023. PMID: 36168329 Free PMC article. Review.

2

Providing Access To Monoclonal Antibody Treatment Of Coronavirus (COVID-19) Patients In Rural And Underserved Areas.

Wood DA, Aleem A, Davis D. Wood DA, et al. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34662052 Free Books & Documents.

3

Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations.

Aleem A, Vaqar S. Aleem A, et al. 2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34033365 Free Books & Documents.

4

Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19).

Aleem A, Akbar Samad AB, Vaqar S. Aleem A, et al. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34033342 Free Books & Documents.

5

Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.

Abdurrahman L, Fang X, Zhang Y. Abdurrahman L, et al. Curr Mol Med. 2022;22(7):621-639. doi: 10.2174/1566524021666211013121831. Curr Mol Med. 2022. PMID: 34645374 Review.

6

Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus (COVID-19) In The Emergency Department.

Aleem A, Olarewaju O, Pozun A. Aleem A, et al. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34662075 Free Books & Documents.

7

Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.

Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Tammam SN, et al. J Control Release. 2021 Sep 10;337:258-284. doi: 10.1016/j.jconrel.2021.07.028. Epub 2021 Jul 20. J Control Release. 2021. PMID: 34293319 Free PMC article. Review.

8

Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.

Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Varahachalam SP, et al. Int J Nanomedicine. 2021 Jan 22;16:539-560. doi: 10.2147/IJN.S283686. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33519200 Free PMC article. Review.

9

Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.

Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali M, Scott JA, Vitale F, Unal MA, Mattevi C, Bedognetti D, Merkoçi A, Tasciotti E, Yilmazer A, Gogotsi Y, Stellacci F, Delogu LG. Weiss C, et al. ACS Nano. 2020 Jun 23;14(6):6383-6406. doi: 10.1021/acsnano.0c03697. Epub 2020 Jun 10. ACS Nano. 2020. PMID: 32519842 Review.

10

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.

Sahin G, Akbal-Dagistan O, Culha M, Erturk A, Basarir NS, Sancar S, Yildiz-Pekoz A. Sahin G, et al. J Pharm Sci. 2022 Oct;111(10):2652-2661. doi: 10.1016/j.xphs.2022.06.004. Epub 2022 Jun 9. J Pharm Sci. 2022. PMID: 35691607 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year